EGFR and familial pancreatic carcinoma: Consistent with these reports, our results illustrated that CKI can inhibit the proliferation of pancreatic cancer cells, arrest cell cycle and downregulate the expression levels of p-CDK1, p-JAK1, p-EGFR and pMAPK3/1.